Depression and anxiety during pregnancy: Clinical aspects

Current Psychiatry Reviews

Volumn 9, Issue 4, 2013, Pages 325-330

  Flores Ramos, Mónica ^a   Galindo Sevilla, Norma ^a   Barrios, Armando Córdova ^a   Gelman, Phillipe Leff ^a   Fuentes, Carlos Cruz ^b   Mancilla Ramírez, Javier ^a  

^a INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

Author keywords

Antidepressants; Anxiety; Anxiolytic; Depression; Pregnancy

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; LAXATIVE; MIRTAZAPINE; NORADRENALIN; PAROXETINE; PSYCHOTROPIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

AGITATION; ALCOHOL CONSUMPTION; ANENCEPHALUS; ANXIETY DISORDER; APGAR SCORE; BECK DEPRESSION INVENTORY; BIRTH WEIGHT; CONGENITAL MALFORMATION; CONVULSION; CRANIOFACIAL SYNOSTOSIS; DEPRESSION; EDINBURGH POSTNATAL DEPRESSION SCALE; EDUCATIONAL STATUS; HUMAN; INCOME; LENGTH OF STAY; LUNG DISEASE; OMPHALOCELE; PARTNER VIOLENCE; PREGNANCY DISORDER; PRIORITY JOURNAL; PUERPERAL DEPRESSION; PULMONARY HYPERTENSION; REVIEW; SMOKING; SOCIAL STATUS; SOCIAL SUPPORT; SUICIDE; UNPLANNED PREGNANCY;

EID: 84888109034     PISSN: 15734005     EISSN: 18756441     Source Type: Journal    
DOI: 10.2174/15734005113096660010     Document Type: Review

References (92)

1. Gaynes BN, Gavin N, Meltzer Brody S, Lohr KN, Swinson T, Gartlehner G et al. Perinatal depression: Prevalence, screening accuracy, and screening outcomes. Evid. Rep. Technol. Asses. (Summ) 2005; 119: 1-8.
2. Alder J, Fink N, Bitzer J, Hösli L, Holzgreve W. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J. Matern. Fetal Neonatal Med. 2007; 20(3): 189-209.
3. American Psychiatric Association. DSM-IV-TR. Manual diagnósticoy estadístico de los trastornos mentales IV. Barcelona Masson, 2003.
4. Murray CJL, López AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. The Lancet 1997; 349: 1498-1504.
5. Seedat S, Scott KM, Angermeyer MC, Berglund P, Bromet EJ, Brugha TS et al. Cross-national associations between gender and mental disorders in the WHO World Mental Health Surveys. Arch. Gen. Psychiatry 2009; 66(7): 785-795.
6. Soares CN, Zytek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: A continuum of vulnerability?. J. Psychiatry Neurosci. 2008; 33(4): 331-343.
7. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG et al. Cross-National epidemiology of Major depression and Bipolar disorder. JAMA 1996; 276(4): 293-299.
8. Ortega L, Lartigue T, Figueroa ME. Prevalencia de depresión a través de la escala perinatal de Edimburgo (EPDS). Perinatol. Reprod. Hum. 2001; 15: 11-21.
9. Lara MA, Navarro C, Navarrete L, Cabrera A, Almanza J, Morales F et al. Síntomas depresivos en el embarazo y factores asociados, en pacientes de tres instituciones de la ciudad de México. Salud Mental 2006; 29(4): 55-62.
10. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet. Gynecol. 2004; 103: 698-709.
11. Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen. Hosp. Psychiatry 2009; 31(5): 403-413.
12. O'Hara MW. Social support, life events, and depression during pregnancy and the puerperium. Arch. Gen. Psychiatry 1986; 43(6): 569-573.
13. Senturk V, Abas M, Berksun O, Stewart R. Social support and antenatal depression in extended and nuclear family environments in Turkey: a cross-sectional survey. BMC Psychiatry 2011; 24: 11-48.
14. Collins NL, Dunkel-Schetter C, Lobel M, Scrimshaw SC. Social support in pregnancy: psychosocial correlates of birth outcomes and postpartum depression. J. Pers. Soc. Psychol. 1993; 65(6): 1243-1258.
15. Hartley M, Tomlinson M, Greco E, Scott Comulada W, Stewart J, le Roux I et al. Depressed mood in pregnancy: prevalence and correlates in two Cape Town peri-urban settlements. Reprod. Health 2011; 2: 8-9.
16. Melville JL, Gavin A, Guo Y, Fan M, Katon WJ. Depressive disorders during pregnancy. Prevalence and risk factors in a large Urban sample. Obstet. Gynecol. 2010; 116: 1064-1070.
17. Valentine JM, Rodriguez MA, Lapeyrouse L, Zhang M. Recent intimate partner violence as a prenatal predictor of maternal depression in the first year postpartum among Latinas. Arch. Womens Ment. Health. 2011; 14(2): 135-143.
18. Lancaster CA, Gold KJ, Flynn HA, Yoo H, Marcus SM, Davis MM. Risk factors for depressive symptoms during pregnancy: a systematic review. Am. J. Obstet. Gynecol. 2010; 202(1): 5-14.
19. Alvarado R, Perucca E, Neves E, Rojas M, Monardes J, Olea E et al. Cuadros depresivos durante el embarazo y factores asociados. Rev. Chil. Obstet. Ginecol. 1993; 58(2): 135-141.
20. Nasreen HE, Kabir ZN, Forsell Y, Edhborg M. Prevalence and associated factors of depressive and anxiety symptoms during pregnancy: a population based study in rural Bangladesh. BMC Womens Health 2011; 11: 22.
21. Lindahl V, Pearson JL, Colpe L. Prevalence of suicidality during pregnancy and the postpartum. Arch. Women Ment. Health. 2005; 8 (2): 77-87.
22. Lancaster C, Singh V, Campbell J, Flynn H, Gold KJ. Homicide and suicide during the perinatal period. Obstet. Gynecol. 2011; 118: 1056-63.
23. Benute GR, Nomura MR, Jorge VM, Nonnenmacher D, Fráquas Jr R, Lucia MC et al. Risk of suicide in high risk pregnancy: an exploratory study. Rev. Assoc. Med. Bras. 2011; 57(5): 583-587.
24. Czeizel AE. Attempted suicide and pregnancy. J. Inj. Violence Res. 2011; 3(1): 45-54.
25. Gentile S. Suicidal mothers. J. Inj. Violence Res. 2011; 3(2): 90-97.
26. Pinheiro RT, da Silva RA, Magalhaes PV, Horta BL, Pinheiro K. A. Two studies on suicidality in the postpartum. Acta Psych. Scand. 2008; 118(2): 160-163.
27. Zuckerman B, Amaro H, Bauchner H, Cabral H. Depressive symptoms during pregnancy: relationship to poor health behaviors. Am. J. Obstet. Gynecol. 1989; 160: 1107-1111.
28. Leis JA, Heron J, Stuart EA, Mendelson T. Association between depressive and anxious symptoms and prenatal alcohol use. Matern. Child Health 2012; 16(6): 1304-1311.
29. Fowles ER Murphey C. Nutrition and mental health in early pregnancy: a pilot study. J Midwifery Womens Health 2009; 54(1): 73-77.
30. Palladino LC, Flynn HA, Richardson C, Marcus SM, Johnson TR, Davis M. M. Lengthened predelivery stay and antepartum complications in women with depressive symptoms during pregnancy. J. Womens Health (Larchmt) 2011; 20(6): 953-962.
31. Wilson LM, Reid AJ, Midmer DK, Bringer A, Carroll JC, Stewart DE. Antenatal psychosocial risk factors associated with adverse postpartum family outcomes. CMAJ 1996; 154(6): 785-799.
32. Piacentini D, Leveni D, Primerano G, Cattaneo M, Volpi L, Biffi G et al. Prevalence and risk factors of postnatal depression among women attending antenatal courses. Epidemiol. Psychiatr. Soc. 2009; 18(3): 214-220.
33. McFarland J, Salisbury AL, Battle CL, Hawes K, Halloran K, Lester BM. Major depressive disorder during pregnancy and emotional attachment to the fetus. Arch. Womens Ment. Health. 2011; 14(5): 425-434.
34. Surkan PJ, Kennedy CE, Hurley KM, Black MM. Maternal depression and childhood growth in developing countries: systematic review and meta-analysis. Bull. World Health Org. 2011; 287: 607-615D.
35. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch. Gen. Psychiatry 2010; 67(10): 1012-1024.
36. Goedhart G, Snijders AC, Hesselink AE, van Poppel MN, Bonsel GJ, Vrijkottie TG. Maternal depressive symptoms in relation to perinatal mortality and morbidity: results from a large multiethnic cohort study. Psychosom. Med. 2010; 72: 769-76.
37. Andersson L, Sundstrom-Poromaa I, Wulff M, Astrom M, Bixo M. Neonatal outcome following maternal antenatal depression and anxiety: a population-based study. Am. J. Epidemiol. 2004; 159: 872-81.
38. Hoffman S, Hatch MC. Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women. Heath Psychol. 2000; 19: 535-43.
39. Straub H, Adams M, Kim JJ, Silver RK. Antenatal depressive symptoms increase the likelihood of preterm birth. Am. J. Obstet. Gynecol. 2012; 207(4): 329.
40. Bonari L, Pinto N, Ahn E, Einarson A, Steiner M, Coren G. Perinatal risks of untreated depression during pregnancy. Can. J. Psychiatry 2004; 49(11): 726-735.
41. Moawad AH, Goldenberg RL, Mercer B, Meis PJ, Iams JD, Das A et al. The preterm prediction study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth. Am. J. Obstet. Gynecol. 2002; 186(5): 990-996.
42. Madhwa PD, Garite TJ, Porto M, Glynn L, Chicz-DeMet A, Dunkel-Schetter C et al. Placental corticotropin-releasing hormone(CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am. J. Obstet. Gynecol. 2004; 191(4): 1063-1069.
43. Field T, Diego M, Hernandez-Reif M. Prenatal depression effects on the fetus and new-born: a review. Infant. Behav. Dev. 2006; 29: 445-455.
44. Lamers F, van Oppen P, Comijs CH, Smit JH, Spinhoven P, van Balkom AJ et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J. Clin. Psychiatry 2011; 72(3): 341-348.
45. Ibanez G, Charles MA, Forhan A, Magnin G, Thiebaugeorges O, Kaminsky M et al. Depression and anxiety in women during pregnancy and neonatal outcome: Data from the EDEN motherchild cohort. Early Hum. Dev., 2012, 88(8), 643-649.
46. Ali, N. S.; Azam, I. S.; Ali, B. S.; Tabbusum, G.; Moin, S. S. Frequency and associated factors for anxiety and depression in pregnant women: a hospital based cross-sectional study. Scientific World Journal 2012; PMID: 22629180 [abstract in PubMed].
47. Herson J, O'Connor T, Evans J, Golding J, Glover V. The ALSPAC Study Team. The Course of anxiety and depression through pregnancy and the postpartum in a community sample. J. Affect. Disord. 2004; 80: 65-73.
48. Perkin M. Cited studies did not show relation between maternal anxiety and birth weight. BMJ. 1999; 318(7193): 1288.
49. Teixeira J, Fisl N, Glover V. Association between maternal anxiety in pregnancy and increased uterine artery resistance index. Cohort based study. BMJ 1999; 318: 153-157.
50. Araújo DM, Pereira N, Kac G. Anxiety during pregnancy, prematurity and low birth weight: a systematic literature review. Cad. Saude Publica 2007; 23(4): 747-756.
51. Rondó P, Ferreira R, Nogueira F, Ribeiro M, Lobert H, Artes R. Maternal psychological stress and distress as predictors of low birth weight, prematurity and intrauterine growth retardation. Eur. J. Clin. Nutr. 2003; 57: 266-272.
52. Berle J, Mykletun A, Daltveit A, Rasmussen S, Holsten F, Dahl A. Neonatal outcomes in offspring of women with anxiety and depression during pregnancy. A linkage study from the Nord-Trondelag Health Study (HUNT) and Medical Birth Registry of Norway. Arch. Womens Ment. Health 2005; 8: 181-189.
53. Austin M, Hadzi-Pavlovic D, Leader L, Saint K, Parker G. Maternal trait anxiety, depression and life event stress in pregnancy: relationships with infant temperament. Early Hum. Dev. 2005; 81: 183-190.
54. Bánhidy F, Acs N, Puhó E, Czeizel AE. Association between maternal panic disorders and pregnancy complications and delivery outcomes. Eur. J. Obtet. Gynecol. Reprod. Biol. 2006; 124(1): 47-52.
55. Uguz F, Gezginc K, Yazici F. Are major depression and generalized anxiety disorder associated with intrauterine growth restriction in pregnant women? A case-control study. Gen. Hosp. Psychiatry 2011; 33(6): 640.
56. Field T, Diego M, Hernandez-Rief M, Figuereido B, Deeds O, Ascencio A et al. Comorbid depression and Anxiety effects on pregnancy and neonatal outcomes. Infant. Behav. Dev. 2010; 33(1): 23.
57. Bhutta A, Cloves M, Casey PH, Cradock MM, Anand KJ. Cognitive and behavioral outcomes of School-aged children who were born pre-term: a meta-analysis. JAMA 2002; 288: 728-37.
58. Saigal S, Doyle D. An overview of Mortality and Squealed of preterm birth from infancy to childhood. Lancet 2008; 371: 261-9.
59. Hofman PL, Cutfield WS. Insulin sensitivity in people born preterm, with low or very low birth weight and small for gestational age. J. Endocrinol. Invest. 2006; 29(1): 2-8.
60. Allin M, Rooney M, Graftth T, Cuddy M, Wyatt J, Rifkin L et al. Neurological Abnormalities in young adults born pre-term. J. Neural Neurosurg. Psychiatry 2006; 77: 495-9.
61. Mancuso RA, Dunkel C, Rini CM, Roesch SC, Hobel KJ. Maternal Prenatal Anxiety and Corticotropin-Releasing Hormone Associated With Timing of Delivery. Psychosom. Med. 2004; 66(5): 762-769.
62. Diego MA, Jones NA, Field T, Hernandez-Rief M, Schanberg S, Kuhn C et al. Maternal psychological distress, prenatal cortisol, and fetal weight. Psychosom. Med. 2006; 68(5): 747-753.
63. Desai G, Babu GN, Chandra PS. Unplanned pregnancies leading to psychotropic exposure in women with mental illness-Findings from a perinatal psychiatry clinic. Indian J. Psychiatry 2012; 54(1): 59-63.
64. Klieger-Grossmann C, Weitzner B, Panchaud A, Pistelli A, Einarson T, Koren G et al. Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study. J. Clin. Pharmacol. 2012; 52(5): 766-770.
65. Nakhai-Pour HR, Broy P, Bérard A. Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ; 182(10): 1031-1037.
66. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993; 269(17): 2246-2248.
67. Einarson A, Choi J, Einarson TR, Koren G. Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J. Obstet. Gynaecol. Can. 2009; 31(5): 452-456.
68. Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Di Gianantonio E et al. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br. J. Clin. Pharmacol. 2008; 66(5): 695-705.
69. Wen SW, Yang Q, Garner P, Fraser W, Olatunbosun O, Nimrod C et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am. J. Obstet. Gynecol. 2006; 194(4): 961-966.
70. Ornoy A, Arnon J, Shechtman S, Moerman L, Lukashova I. Is benzodiazepine use during pregnancy really teratogenic?. Reproductive Toxicology 1998; 12(5): 511-515.
71. Ban L, Tata LJ, West J, Fiaschi L, Gibson JE. Live and Non-Live Pregnancy Outcomes among Women with Depression and Anxiety: A Population-Based Study. PLoS ONE 2012; 7(8): e43462.
72. Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am. J. Psychiatry 2002; 159: 2055-61.
73. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch. Gen. Psychiatry 2006; 63: 898-906.
74. Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J. Clin. Psychopharmacol 2012; 32(2): 186-194.
75. Hayes RM, Wu P, Shelton RC, Cooper WO, Dupont WD, Mitchel E et al. Maternal antidepressant use and adverse outcomes: a cohort study of 228, 876 pregnancies. Am. J. Obstet. Gynecol. 2012; 207(1): 49.
76. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N. Engl. J. Med. 2006; 354: 579-87.
77. ter Horst PG, Bos HJ, de Jong-van de Berg LT, Wiffert B. In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children. Eur. J. Clin. Pharmacol 2013; 69(3): 541-547.
78. Nijenhuis CM, ter Horst PG, van Rein M, Wilfert B, de Jong-van de Berg LT. Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses. Br. J. Clin. Pharmacol 2012; 73(1): 126-134.
79. Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C et al. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update. Postgrad. Med. 2010; 122(4): 49-65.
80. Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H et al. Paroxetin and congenital malformations: meta-analysis and consideration of potential confounding factors. Clin. Ther. 2007; 29 (5): 918-926.
81. Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. National Birth Defects Prevention Study. NEJM 2007; 356: 2684-92.
82. ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet. Gynecol. 2008; 111(4): 1001-1020.
83. Djulus J, Koren G, Einarson TR, Wilton R, Shakir S, Diav-Citrin O et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J. Clin. Psychiatry 2006; 67(8): 1280-1284.
84. Lennestal R, Källén B. Delivery outcome in relation to maternal use of some recently introduced antidepressants. J. Clin. Psychopharmacol 2007; 27(6): 607-613.
85. Gentile S. Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depress. Anxiety 2010; 27(7): 675-686.
86. Eberhard-Gran M, Eskild A, Opjordsmoen S. Treating mood disorders during pregnancy: safety considerations. Drug Saf. 2005; 28(8): 695-706.
87. Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and casecontrol studies. BMJ 1998; 317: 839-43.
88. Uzun S, Kosumplic O, Jakovljevik M, Sedic V. Side effects of treatment with benzodiazepines. Psychiatr. Danub 2010; 22(1): 90-93.
89. Nanzer N, Sancho Rossignol A, Righetti-Veltema M, Knauer D, Manzano J, Palacio Espasa S. Effects of a brief psychoanalytic intervention for perinatal depression. Arch. Womens Ment. Health 2012; 15(4): 259-268.
90. Dunn C, Hanieh E, Roberts R, Powrie R. Mindful pregnancy and childbirth: effects of a mindfulness-based intervention on women's psychological distress and well-being in the perinatal period. Arch. Womens Ment. Health 2012; 15(2): 139-143.
91. Sockol LE, Epperson CN, Barber JP. A meta-analysis of treatments for perinatal depression. Clin. Psycol. Rev. 2011; 31(5): 839-849.
92. Marc I, Toureche N, Ernst E, Hodnett ED, Blanchet C, Dodin S et al. Mind-body interventions during pregnancy for preventing or treating women anxiety. Cochrane Database Syst Rev 2011; (7): CD007559.